首页> 美国卫生研究院文献>other >Generalized Redistribute-to-the-Right Algorithm: Application to the Analysis of Censored Cost Data
【2h】

Generalized Redistribute-to-the-Right Algorithm: Application to the Analysis of Censored Cost Data

机译:广义右分配算法:在删失成本数据分析中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Medical cost estimation is a challenging task when censoring of data is present. Although researchers have proposed methods for estimating mean costs, these are often derived from theory and are not always easy to understand. We provide an alternative method, based on a replace-from-the-right algorithm, for estimating mean costs more efficiently. We show that our estimator is equivalent to an existing one that is based on the inverse probability weighting principle and semiparametric efficiency theory. We also propose an alternative method for estimating the survival function of costs, based on the redistribute-to-the-right algorithm, that was originally used for explaining the Kaplan–Meier estimator. We show that this second proposed estimator is equivalent to a simple weighted survival estimator of costs. Finally, we develop a more efficient survival estimator of costs, using the same redistribute-to-the-right principle. This estimator is naturally monotone, more efficient than some existing survival estimators, and has a quite small bias in many realistic settings. We conduct numerical studies to examine the finite sample property of the survival estimators for costs, and show that our new estimator has small mean squared errors when the sample size is not too large. We apply both existing and new estimators to a data example from a randomized cardiovascular clinical trial.
机译:当存在数据审查时,医疗费用估算是一项具有挑战性的任务。尽管研究人员提出了估算平均成本的方法,但这些方法通常是从理论中得出的,并不总是易于理解。我们提供了一种基于权利替代算法的替代方法,可以更有效地估算平均成本。我们表明,我们的估计器等效于基于逆概率加权原理和半参数效率理论的现有估计器。我们还提出了一种基于成本再分配算法的估计成本生存函数的替代方法,该算法最初用于解释Kaplan-Meier估计器。我们表明,第二个提议的估计量等同于简单的加权生存成本估计量。最后,我们使用相同的按权利分配原则,开发了一种更有效的成本生存估算器。该估算器自然是单调的,比某些现有的生存估算器更有效,并且在许多实际情况下偏差很小。我们进行了数值研究,以检验生存估计量的有限样本属性的成本,并表明当样本量不太大时,我们的新估计量具有较小的均方误差。我们将现有估计数和新估计数应用于来自随机心血管临床试验的数据示例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号